July 2026
The global facial injectable market size is expected to increase from USD 14.41 billion in 2025 to hit around USD 44.05 billion by 2035, with a CAGR of 11.82%.
July 2026
The global generic injectable market size is expected to increase from USD 133.34 billion in 2025 and is expected to reach around USD 482.50 billion by 2035 with a CAGR of 13.72%.
July 2026
The global facial palsy market size was evaluated at USD 2.63 billion in 2025 and is predicted to hit around USD 4.29 billion by 2035, growing at a CAGR of 5.02%.
June 2026
The global sterile injectables CDMO market size is estimated to hit around USD 11.82 billion by 2035 from USD 4.73 billion in 2025, with a CAGR of 9.59%.
June 2026
The global knee osteoarthritis injectable treatments market size is estimated to hit around USD 6.78 billion by 2035 from USD 3.46 billion in 2025, with a CAGR of 6.96%.
June 2026
The U.S. generic sterile injectable market size was evaluated at USD 17.91 billion in 2025 and is predicted to hit around USD 43.26 billion by 2035, growing at a CAGR of 9.22%.
May 2026
The global aesthetic injectables market size is estimated to hit around USD 43.98 billion by 2035 increasing from USD 13.81 billion in 2025, with a CAGR of 12.28%.
May 2026
The global injectable peptides drugs market size was evaluated at USD 48.60 billion in 2025 and is predicted to hit around USD 117.18 billion by 2035, growing at a CAGR of 9.20%.
March 2026
The global non-injectable insulin market size is expected to increase from USD 1.88 billion in 2025 and is expected to hit around USD 5.63 billion by 2034 at a CAGR of 12.99%.
February 2026
The generic sterile injectable market size is estimated to hit around USD 124.44 billion by 2035 increasing from USD 51.17 billion in 2025, with a CAGR of 9.29%.
January 2026
The injectable drug delivery market size was valued at USD 764.6 billion in 2025 and is projected to hit around USD 1,719.57 billion by 2035 with a CAGR of 8.45%.
January 2026
The global facial recognition market size is valued at USD 9.30 billion in 2025 and is projected to attain around USD 36.75 billion by 2035 with a CAGR of 14.73%.
December 2025
The global facial implant market size is accounted at USD 3.39 billion in 2025 and is expected to hit around USD 6.09 billion by 2035 with a CAGR of 6.03%.
August 2025
The global long-acting injectables (LAIs) market size was evaluated at USD 16.94 billion in 2024 and is predicted to hit around USD 57.26 billion by 2034, growing at a CAGR of 12.95%.
August 2025
The global injectable cytotoxic drugs market size is estimated to hit around USD 35.71 billion by 2034 increasing from USD 19.48 billion in 2024, with a CAGR of 6.25%.
July 2025
The lyophilized injectable drugs market size was valued at USD 353.67 billion in 2024 and is expected to attain around USD 1,330.78 billion by 2034, with a CAGR of 8.84%.
June 2025
The global facial skincare market size was estimated at USD 101.74 billion in 2024 and is expected to hit around USD 178.58 billion by 2034, growing at a CAGR of 5.79%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com